Haverford Financial Services, Inc. Gsk PLC Transaction History

Haverford Financial Services, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 08, 2018	SELL	$39.75 - $42.69 $303,133 - $325,553	-7,626 Closed	0 $0
Q2 2018 Aug 10, 2018	SELL	$39.61 - $42.76 $87,379 - $94,328	-2,206 Reduced 22.44%	7,626 $307,000
Q1 2018 May 09, 2018	SELL	$36.18 - $40.15 $32,200 - $35,733	-890 Reduced 8.3%	9,832 $384,000
Q4 2017 Feb 13, 2018	BUY	$35.34 - $41.9 $181,223 - $214,863	5,128 Added 91.67%	10,722 $380,000
Q2 2017 Aug 14, 2017	BUY	N/A	5,594	5,594 $241,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Haverford Financial Services, Inc., based on Form 13F filings with the SEC.

Stay updated on Haverford Financial Services, Inc. with notifications on news.